Stem cell therapy for multiple sclerosis: preclinical evidence beyond all doubt?

Author： Reekmans Kristien   Praet Jelle   De Vocht Nathalie   Daans Jasmijn   Van der Linden Annemie   Berneman Zwi   Ponsaerts Peter  

Publisher： Future Medicine

ISSN： 1746-0751

Source： Regenerative Medicine, Vol.7, Iss.2, 2012-03, pp. : 245-259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

B‐cell Therapy for Multiple Sclerosis: Entering an era

By  

ANNALS OF NEUROLOGY, Vol. 83, Iss. 1, 2018-01 ,pp. : 13-26

John Wiley & Sons Inc

Access to resources Recommend Favorite

Dose response to interferon therapy in multiple sclerosis: an evaluation of the evidence

By Freedman S. Mitchell  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 547-557

Informa Healthcare

Access to resources Recommend Favorite

Look beyond the door, not through the keyhole: evidence from a cognitive assessment including social cognition evaluation in multiple sclerosis

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 25, Iss. 2, 2018-02 ,pp. : 205-206

John Wiley & Sons Inc

Access to resources Recommend Favorite

Stem cell therapies for systemic sclerosis

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 3, 2015-02 ,pp. : 328-337

John Wiley & Sons Inc

Access to resources Recommend Favorite

Detection of Chlamydia Pneumoniae in the Cerebrospinal Fluid of Patients with Multiple Sclerosis by Combination of Cell Culture and PCR: No Evidence for Possible Association

By Chatzipanagiotou S.  

Molecular Diagnosis, Vol. 7, Iss. 1, 2003-01 ,pp. : 41-43

Adis International

Access to resources Recommend Favorite